Figure 1.
Participant flow. FIRST, Ferriprox in Patients with Iron Overload in Sickle Cell Disease Trial; ITT, intent-to-treat; SCD, sickle cell disease.

Participant flow. FIRST, Ferriprox in Patients with Iron Overload in Sickle Cell Disease Trial; ITT, intent-to-treat; SCD, sickle cell disease.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal